Global Spatial Proteomics Market Size Study, By Product (Instruments, Consumables, Software), By Technology (Imaging-Based, Mass Spectrometry-Based, Sequencing-Based), By Workflow (Sample Preparation, Instrumental Analysis, Data Analysis), By Sample Type (FFPE, Fresh Frozen), By End-Use (Academic & Translational Research Institutes, Pharmaceutical & Biotechnology Companies), and Regional Forecasts 2022-2032

January 2025 | 285 pages | ID: G15D003FD622EN
Bizwit Research & Consulting LLP

Abstracts

The Global Spatial Proteomics Market was valued at USD 77.6 million in 2023 and is expected to grow at a CAGR of 14.76% over the forecast period 2024-2032, reaching USD 267.9million by 2032. The market’s rapid expansion is fueled by advancements in imaging technologies, sequencing platforms, and increasing adoption in personalized medicine, oncology, and biomarker discovery.

Spatial proteomics, which enables the visualization and quantification of proteins within native tissue environments, is transforming biomedical research. Technologies such as Imaging Mass Cytometry (IMC), Multiplexed Ion Beam Imaging (MIBI), and next-generation sequencing (NGS) are at the forefront, facilitating high-resolution, spatially-resolved protein analysis. The adoption of spatial proteomics in cancer research has been particularly impactful, aiding the study of tumor microenvironments and advancing targeted therapies.

The growing need for data-driven precision medicine, coupled with increasing R&D investments by pharmaceutical and biotechnology companies, is a significant driver of market growth. Additionally, innovations such as Curio Bioscience’s Curio Seeker and NanoString’s GeoMx IO Proteome Atlas have strengthened the market by expanding capabilities for high-throughput protein mapping.

North America dominated the market in 2024, accounting for 49.13% of the global share, driven by advanced research infrastructure and significant funding. Asia-Pacific is expected to exhibit the fastest growth due to rising investments in healthcare, expanding research capabilities, and increasing adoption of spatial proteomics technologies in China, Japan, and India.

Major market players included in this report are:

• 10X Genomics
• Bruker
• NanoString Technologies, Inc.
• Akoya Biosciences, Inc.
• Fluidigm Corporation
• PerkinElmer
• Danaher
• Biotechne
• S2 Genomics, Inc.
• Seven Bridges Genomics Inc.
• Lunaphore Technologies
• Cayman Chemical
• Navinci Diagnostics
• Thermo Fisher Scientific
• Cytiva

The detailed segments and sub-segments of the market are explained below:

By Product:

• Instruments
• Automated
• Semi-Automated & Manual
• Consumables
• Software

By Technology:

• Imaging-Based Technologies
• Mass Spectrometry-Based Technologies
• Sequencing-Based Technologies
• Other Technologies

By Workflow:

• Sample Preparation
• Instrumental Analysis
• Data Analysis

By Sample Type:

• FFPE
• Fresh Frozen

By End-Use:

• Academic & Translational Research Institutes
• Pharmaceutical & Biotechnology Companies
• Other End-Use

By Region:

North America

• U.S.
• Canada
• Mexico

Europe

• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway

Asia Pacific

• China
• Japan
• India
• South Korea
• Australia
• Thailand

Latin America

• Brazil
• Argentina

Middle East & Africa

• South Africa
• Saudi Arabia
• UAE
• Kuwait

Years considered for the study are as follows:

• Historical Year: 2022
• Base Year: 2023
• Forecast Period: 2024-2032

Key Takeaways

• Technology Trends: Imaging-based technologies accounted for the largest share, while sequencing-based technologies are expected to grow at the fastest CAGR.
• Key Applications: Cancer research and personalized medicine are driving market demand, particularly in drug discovery and biomarker identification.
• Regional Leadership: North America led the market in 2024 with 49.13% share, while Asia-Pacific is poised for the fastest growth over the forecast period.
• Major Players: Leading market players include 10X Genomics, Bruker, NanoString Technologies, Akoya Biosciences, and PerkinElmer.

Contents

CHAPTER 1. GLOBAL SPATIAL PROTEOMICS MARKET EXECUTIVE SUMMARY

1.1. Global Spatial Proteomics Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
  1.3.1. By Product
  1.3.2. By Technology
  1.3.3. By Workflow
  1.3.4. By Sample Type
  1.3.5. By End-Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

CHAPTER 2. GLOBAL SPATIAL PROTEOMICS MARKET DEFINITION AND RESEARCH ASSUMPTIONS

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
  2.3.1. Inclusion & Exclusion
  2.3.2. Limitations
  2.3.3. Supply Side Analysis
    2.3.3.1. Availability
    2.3.3.2. Infrastructure
    2.3.3.3. Regulatory Environment
    2.3.3.4. Market Competition
    2.3.3.5. Economic Viability (Consumer’s Perspective)
  2.3.4. Demand Side Analysis
    2.3.4.1. Regulatory Frameworks
    2.3.4.2. Technological Advancements
    2.3.4.3. Environmental Considerations
    2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

CHAPTER 3. GLOBAL SPATIAL PROTEOMICS MARKET DYNAMICS

3.1. Market Drivers
  3.1.1. Growing adoption of spatial proteomics in cancer research and drug discovery
  3.1.2. Technological advancements in imaging and sequencing platforms
  3.1.3. Increasing demand for personalized medicine
3.2. Market Challenges
  3.2.1. High costs associated with spatial proteomics technologies
  3.2.2. Limited awareness and accessibility in emerging markets
3.3. Market Opportunities
  3.3.1. Growing applications in neuroscience, immunology, and infectious diseases
  3.3.2. Expansion of spatial proteomics in Asia-Pacific and Latin America

CHAPTER 4. GLOBAL SPATIAL PROTEOMICS MARKET INDUSTRY ANALYSIS

4.1. Porter’s Five Forces Analysis
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s Five Forces Model
  4.1.7. Porter’s Five Force Impact Analysis
4.2. PESTEL Analysis
  4.2.1. Political
  4.2.2. Economic
  4.2.3. Social
  4.2.4. Technological
  4.2.5. Environmental
  4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL SPATIAL PROTEOMICS MARKET SIZE & FORECASTS BY PRODUCT (2022-2032)

5.1. Segment Dashboard
5.2. Instruments
  5.2.1. Automated
  5.2.2. Semi-Automated & Manual
5.3. Consumables
5.4. Software

CHAPTER 6. GLOBAL SPATIAL PROTEOMICS MARKET SIZE & FORECASTS BY TECHNOLOGY (2022-2032)

6.1. Segment Dashboard
6.2. Imaging-Based Technologies
6.3. Mass Spectrometry-Based Technologies
6.4. Sequencing-Based Technologies
6.5. Other Technologies

CHAPTER 7. GLOBAL SPATIAL PROTEOMICS MARKET SIZE & FORECASTS BY WORKFLOW (2022-2032)

7.1. Segment Dashboard
7.2. Sample Preparation
7.3. Instrumental Analysis
7.4. Data Analysis

CHAPTER 8. GLOBAL SPATIAL PROTEOMICS MARKET SIZE & FORECASTS BY SAMPLE TYPE (2022-2032)

8.1. Segment Dashboard
8.2. FFPE
8.3. Fresh Frozen

CHAPTER 9. GLOBAL SPATIAL PROTEOMICS MARKET SIZE & FORECASTS BY END-USE (2022-2032)

9.1. Segment Dashboard
9.2. Academic & Translational Research Institutes
9.3. Pharmaceutical & Biotechnology Companies
9.4. Other End-Uses

CHAPTER 10. GLOBAL SPATIAL PROTEOMICS MARKET SIZE & FORECASTS BY REGION (2022-2032)

10.1. North America
  10.1.1. U.S.
  10.1.2. Canada
  10.1.3. Mexico
10.2. Europe
  10.2.1. UK
  10.2.2. Germany
  10.2.3. France
  10.2.4. Italy
  10.2.5. Spain
  10.2.6. Denmark
  10.2.7. Sweden
  10.2.8. Norway
  10.2.9. Rest of Europe
10.3. Asia-Pacific
  10.3.1. China
  10.3.2. Japan
  10.3.3. India
  10.3.4. South Korea
  10.3.5. Australia
  10.3.6. Thailand
  10.3.7. Rest of Asia-Pacific
10.4. Latin America
  10.4.1. Brazil
  10.4.2. Argentina
  10.4.3. Rest of Latin America
10.5. Middle East & Africa
  10.5.1. Saudi Arabia
  10.5.2. UAE
  10.5.3. South Africa
  10.5.4. Kuwait
  10.5.5. Rest of Middle East & Africa

CHAPTER 11. COMPETITIVE INTELLIGENCE

11.1. Key Company SWOT Analysis
  11.1.1. 10X Genomics
  11.1.2. Bruker
  11.1.3. NanoString Technologies, Inc.
11.2. Top Market Strategies
11.3. Company Profiles
  11.3.1. 10X Genomics
  11.3.2. Bruker
  11.3.3. NanoString Technologies, Inc.
  11.3.4. Akoya Biosciences, Inc.
  11.3.5. PerkinElmer
  11.3.6. Fluidigm Corporation
  11.3.7. Danaher
  11.3.8. Biotechne
  11.3.9. Lunaphore Technologies
  11.3.10. Seven Bridges Genomics Inc.

CHAPTER 12. RESEARCH PROCESS

12.1. Research Process
  12.1.1. Data Mining
  12.1.2. Analysis
  12.1.3. Market Estimation
  12.1.4. Validation
  12.1.5. Publishing
12.2. Research Attributes

12. LIST OF TABLES

1. GLOBAL SPATIAL PROTEOMICS MARKET ESTIMATES & FORECASTS BY REGION (2022-2032)

2. GLOBAL SPATIAL PROTEOMICS MARKET ESTIMATES & FORECASTS BY PRODUCT (2022-2032)

3. GLOBAL SPATIAL PROTEOMICS MARKET ESTIMATES & FORECASTS BY TECHNOLOGY (2022-2032)

4. NORTH AMERICA SPATIAL PROTEOMICS MARKET BY PRODUCT (2022-2032)

5. EUROPE SPATIAL PROTEOMICS MARKET BY TECHNOLOGY (2022-2032)

6. ASIA-PACIFIC SPATIAL PROTEOMICS MARKET BY WORKFLOW (2022-2032)

7. TOP KEY PLAYERS AND REVENUE ANALYSIS

12. LIST OF FIGURES

1. GLOBAL SPATIAL PROTEOMICS MARKET SIZE (2022 & 2032)

2. REGIONAL MARKET SHARE ANALYSIS, 2024

3. PRODUCT TRENDS: INSTRUMENTS, CONSUMABLES, SOFTWARE

4. TECHNOLOGY TRENDS: IMAGING-BASED, SEQUENCING-BASED

5. WORKFLOW ANALYSIS: SAMPLE PREPARATION AND INSTRUMENTAL ANALYSIS

6. END-USE MARKET SHARE ANALYSIS

7. ASIA-PACIFIC MARKET GROWTH FORECAST

This list is not complete; the final report contains more than 50 figures.